Pro Medicus Limited (OTCMKTS:PMCUF – Get Free Report) shares gapped up prior to trading on Thursday . The stock had previously closed at $122.42, but opened at $129.94. Pro Medicus shares last traded at $129.94, with a volume of 28 shares traded.
Analyst Ratings Changes
Separately, Jefferies Financial Group downgraded shares of Pro Medicus from a “buy” rating to a “hold” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $155.00.
Check Out Our Latest Stock Analysis on PMCUF
Pro Medicus Stock Up 6.1%
Pro Medicus Company Profile
Pro Medicus Limited is an Australia?based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Further Reading
- Five stocks we like better than Pro Medicus
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
